The most frequent MEK1 mutations in NSCLC are described as amino acids substitutions (K57N, Q56P, D67N) located in exon 2 and they are mutually exclusive with other driver mutations [7–10]. Here, MAP2K1 is linked to non-small cell lung carcinoma.